Experiment summary for ENCSR411NTJ
doi:10.17989/ENCSR411NTJ
Summary
- Status
- released
- Assay
- Mint-ChIP-seq
- Target
- H3K9me3
- Biosample summary
- Homo sapiens stimulated activated naive CD8-positive, alpha-beta T cell male adult (42 years) treated with 100 ng/mL Interleukin-15 for 24 hours, anti-CD3 and anti-CD28 coated beads for 24 hours, 50 U/mL Interleukin-2 for 24 hours
- Biosample Type
- primary cell
- Replication type
- unreplicated
- Description
- H3K9me3 Mint-ChIP-seq on activated CD8-positive, naive alpha-beta T cell male adult (42 years)
- Treatments
- 100 ng/mL Interleukin-15 (UniProtKB:P40933) for 24 hours, anti-CD3 and anti-CD28 coated beads for 24 hours, 50 U/mL Interleukin-2 (UniProtKB:P60568) for 24 hours
- Nucleic acid type
- DNA
- Platform
- Illumina NextSeq 500
- Controls
Attribution
ENCODE4 project
- Lab
- Bradley Bernstein, Broad
- Award
- UM1HG009390 (Bradley Bernstein, Broad)
- Project
- ENCODE
- External resources
- Aliases
- bradley-bernstein:Project Element 6547
- Date released
- June 24, 2021
Isogenic replicates
Isogenic replicate | Technical replicate | Summary | Biosample | Antibody | Library |
|---|---|---|---|---|---|
| 1 | 1 | Homo sapiens male adult (42 years) stimulated activated naive CD8-positive, alpha-beta T primary cell treated with 100 ng/mL Interleukin-15 for 24 hours, anti-CD3 and anti-CD28 coated beads for 24 hours, 50 U/mL Interleukin-2 for 24 hours | ENCBS819MUY | ENCAB003LHL | ENCLB242HVE |
| 1 | 2 | Homo sapiens male adult (42 years) stimulated activated naive CD8-positive, alpha-beta T primary cell treated with 100 ng/mL Interleukin-15 for 24 hours, anti-CD3 and anti-CD28 coated beads for 24 hours, 50 U/mL Interleukin-2 for 24 hours | ENCBS819MUY | ENCAB003LHL | ENCLB782EWU |